WWTR1 and Parkinson disease: Furthermore, BRD-K97481123 can be considered as a potential therapeutic agent for the treatment of PD by targeting TAZ.<h4>Conclusion</h4>By integrating AI pipelines and multi-omics, our study first traced TAZ mechanisms in PD pathogenesis and elaborated on TAZ's predictive and druggable potential for PD patients.